ERFE and type 2 diabetes mellitus: On the contrary, higher levels of plasma myonectin/ERFE were found in individuals with type 2 diabetes and prediabetes in a study by Li et al. [16]; furthermore, positive correlations with WHR, body fat and indicators of glucose metabolism were observed, suggesting that myonectin/ERFE is a predictor of diabetes development.